NYSEAMERICAN:CVM - CEL-SCI Corporation
$2.86
 $0.02
+0.70%
1:05PM EDT
2019-02-22
CEL-SCI Corporation, incorporated on March 22, 1983, is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The Company is focused on activating the immune system to fight cancer and infectious diseases. It operates through the segment of research and development of certain drugs and vaccines. It is focused on the development of product candidates and technologies, including Multikine (Leukocyte Interleukin, Injection) (Multikine), an investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia in human immunodeficiency virus (HIV) and human papillomavirus (HPV) co-infected patients and Ligand Epitope Antigen Presentation System (L.E.A.P.S.) technology, with over two investigational therapies, LEAPS-H1N1-DC, a product candidate under development for the treatment of pandemic influenza in hospitalized patients, and CEL-2000 and CEL-4000, vaccine product candidates under development for the treatment of rheumatoid arthritis.Multikine is being tested in a Phase III clinical trial in primary head and neck cancer. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CVM     avg for
industry  
  avg for
sector  
42 stocks weight:  82. 12   0. 00   0. 00  
42 stocks rank:  2. 05 K 1. 75 K 1. 04 K
# analyst opinions:  1. 00   14. 71   14. 20  

quick ratio:  1. 16   5. 11   1. 74  
current ratio:  1. 35   5. 42   2. 10  

ex-dividend date:     1996-08-27
target price low:  4. 46   90. 14   118. 49  
target price avg:  4. 46   116. 45   142. 48  
target price high:  4. 46   142. 04   163. 43  
1-yr high:  4. 26   124. 43   143. 35  
last close:  2. 77   102. 79   129. 91  
50-day avg:  2. 84   98. 71   122. 84  
200-day avg:  2. 66   100. 04   123. 36  
1-yr low:  0. 83   78. 37   100. 37  
volume:  260. 03 K 2. 53 M 4. 41 M
50-day avg volume:  247. 16 K 3. 20 M 4. 84 M
200-day avg volume:  648. 31 K 3. 17 M 4. 23 M

1-day return:  0. 36 % -0. 26 % -0. 20 %
this week return:  0. 36 % -1. 09 % -0. 43 %
12-wk return:  -15. 55 % 0. 61 % -1. 00 %
52-wk return:  55. 06 % -1. 83 % 15. 65 %

enterprise value (EV):  88. 34 M 55. 56 B 106. 65 B
market cap:  81. 90 M 48. 78 B 97. 32 B
EBITDA:  -16. 23 M 4. 80 B 7. 16 B
enterprise multiple (EV/EBITDA):  -5. 44   9. 43   16. 93  
enterprise/revenue (EV/R):  174. 35   30. 55   23. 98  
total revenue:  506. 65 K 11. 22 B 40. 12 B
total debt:  13. 41 M 13. 64 B 16. 70 B
debt/equity:  495. 38   41. 58   80. 88  
net income (common):  -24. 42 M 2. 37 B 3. 60 B

shares outstanding:  29. 57 M 603. 08 M 1. 22 B
shares:  27. 45 M 602. 41 M 1. 14 B
shares short:  2. 87 M 10. 60 M 11. 84 M
shares short prior month:  2. 54 M 11. 98 M 11. 79 M
short ratio:  8. 47   4. 85   3. 17  
short % of float:  10. 72 % 6. 12 % 2. 78 %
total cash/share:  0. 23   12. 01   10. 06  
total cash:  6. 68 M 7. 38 B 7. 05 B
free cash flow:  -12. 35 M 175. 43 M 2. 45 B
operating cash flow:  -14. 93 M 276. 49 M 3. 08 B

book value:  0. 10   15. 02   29. 01  
price/book:  28. 56   -1. 21   -3. 11  
gross profits:  476. 56 K 8. 46 B 19. 33 B
operating margins:  -3331. 20 % -448. 53 % -625. 18 %
EBITDA margins:  0. 00 % 13. 96 % 22. 59 %
profit margins:  0. 00 % 6. 99 % 10. 07 %
gross margins:  0. 00 % 48. 33 % 54. 27 %

1-yr max volatility:  44. 05 % --- ---
1-yr mean volatility:  0. 48 % 0. 01 % 0. 07 %

1-yr EPS:  -1. 19   3. 09   4. 12  
P/E:  -2. 33   16. 12   29. 23  
PE/G:  -0. 07   1. 22   5. 95  
growth:  31. 30 % 751. 62 % 114. 63 %
earnings high:  -0. 00   1. 34   1. 69  
earnings avg:  -0. 00   0. 98   1. 55  
earnings low:  -0. 00   0. 71   1. 43  
revenue high:  -0. 00   2. 85 B 11. 42 B
revenue avg:  -0. 00   2. 74 B 11. 10 B
revenue low:  -0. 00   2. 65 B 10. 88 B
return on assets:  -43. 85 % -3. 49 % 3. 81 %
revenue growth:  31. 30 % 713. 56 % 106. 99 %
revenue/share:  0. 02   14. 72   60. 38  

beta (1yr vs S&P500):  1. 47   1. 21   0. 94  
sharpe (1yr):  0. 99   0. 06   1. 00  

held % insiders:  5. 42 % 6. 33 % 3. 17 %
held % institutions:  8. 82 % 79. 54 % 70. 80 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-20 : CVM
.    + 0.474 =         0.474 :: INITIAL WEIGHT
.  + 156.819 =       157.293 :: inverse volume-to-price addition
.  + 379.202 =       536.495 :: spline projection addition
.  - 182.008 =       354.487 :: poor performance penalty
.    x 1.547 =       548.563 :: one-year gains+dividend factor
.    x 4.921 =      2699.517 :: 13 weeks' performance factor
.    x 1.476 =      3983.816 :: industry recommendation factor
.    x 3.921 =     15619.564 :: EV/R factor
.    x 0.996 =     15551.064 :: return on assets factor
.    x 2.221 =     34536.762 :: revenue growth factor
.    x 2.248 =     77651.129 :: current ratio factor
.    x 1.922 =     149266.89 :: quick ratio factor
.    x 1.057 =    157832.621 :: short ratio factor
.    x 2.459 =    388143.434 :: price-to-book factor
.     x 2.18 =    846020.557 :: debt-to-equity factor
.    x 1.054 =    891436.043 :: 5-day avg > 200-day avg
.    x 1.068 =    952036.991 :: 50-day avg > 200-day avg
.    x 2.132 =   2030078.257 :: P/E weight
.    x 1.915 =   3887457.572 :: PE/G factor
.    x 1.546 =   6011220.233 :: beta factor
.    x 0.991 =   5959995.132 :: sharpe factor
.    x 1.847 =  11006468.974 :: target low factor
.     x 1.26 =  13869059.568 :: target mean factor
.    x 1.078 =  14951189.711 :: target high factor
.    x 1.006 =  15042437.428 :: industry 12-weeks return
.    x 0.948 =  14261824.011 :: "drift" penalty 3 days ago
.      x 1.0 =  14261575.079 :: overall "drift" factor
.     x 0.56 =   7979689.529 :: largest single-day jump factor
.    x 0.069 =     553760.55 :: low price factor
.      x 1.0 =    553696.699 :: factor hist industry gain for week 07
.   cubeRoot =        82.115 :: reduced for readability
.                     82.115 :: FINAL WEIGHT for NYSEAMERICAN:CVM


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org